Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-04-03 @ 6:57 PM
Study NCT ID:
NCT00174369
Status:
TERMINATED
Last Update Posted:
2009-03-17
First Post:
2005-09-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A4581002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Director, Clinical Trial Disclosure Group
Old Organization:
Pfizer, Inc.